help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-2399
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
92/6/2163    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Steeg, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Steeg, J. W.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Hazardous Substances DB
*MENOTROPINS
Related Collections
Right arrow Female Endocrinology
Right arrow Neuroendocrinology and Pituitary
The Journal of Clinical Endocrinology & Metabolism Vol. 92, No. 6 2163-2168
Copyright © 2007 by The Endocrine Society

Predictive Value and Clinical Impact of Basal Follicle-Stimulating Hormone in Subfertile, Ovulatory Women

Jan W. van der Steeg, Pieternel Steures, Marinus J. C. Eijkemans, J. Dik F. Habbema, Peter G. A. Hompes, Frank J. Broekmans, Peter X. J. M. Bouckaert, Patrick M. M. Bossuyt, Fulco van der Veen, Ben W. J. Mol on behalf of the Collaborative Effort for Clinical Evaluation in Reproductive Medicine (CECERM) Study Group1

Center for Reproductive Medicine (J.W.v.d.S., P.S., F.v.d.V., B.W.J.M.) and Department of Clinical Epidemiology and Biostatistics (P.M.M.B.), Academic Medical Center, 1105 AZ Amsterdam, The Netherlands; Department of Public Health (J.W.v.d.S., P.S., M.J.C.E., J.D.F.H.), Erasmus Medical Center, University Medical Center Rotterdam, 3000 DR Rotterdam, The Netherlands; Department of Obstetrics and Gynecology (J.W.v.d.S., P.S., P.G.A.H.), Vrije Universiteit Medical Center, 1081 HV Amsterdam, The Netherlands; Division of Reproductive Medicine (F.J.B.), Department of Perinatology and Gynaecology, University Medical Center, 3508 GA Utrecht, The Netherlands; Department of Obstetrics and Gynecology (P.X.J.M.B.), Atrium Medisch Centrum, 3503 RE Heerlen, The Netherlands; and Department of Obstetrics and Gynecology (B.W.J.M.), Máxima Medical Center, 5500 MB Veldhoven, The Netherlands

Address all correspondence and requests for reprints to: Jan Willem van der Steeg, Academic Medical Center, Center of Reproductive Medicine, Room H4-213, Department of Obstetrics/Gynecology, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. E-mail: j.w.vandersteeg{at}amc.uva.nl.

Context: Basal FSH is a marker for ovarian reserve.

Objectives: The objective of the study was to investigate the predictive value of basal FSH on spontaneous ongoing pregnancy in subfertile ovulatory women.

Design: This was a prospective cohort study.

Setting: The study was conducted in 19 fertility centers in The Netherlands.

Participants: Subfertile ovulatory women without two-sided tubal pathology and in whom the man had normal sperm parameters (total motile count ≥ 3 x106) participated in the study.

Interventions: Interventions included a fertility work-up, including a basal FSH measurement on cycle d 3.

Main Outcome Measures: Spontaneous ongoing pregnancy was measured.

Results: We included 3519 consecutive couples of which 562 (16%) had a spontaneous ongoing pregnancy within 1 yr. Basal FSH levels of 8 IU/liter or higher were associated with a decreased probability of spontaneous ongoing pregnancy [hazard ratio (HR) 0.93/IU·liter (95% confidence interval [CI] 0.87–0.98)]. In a multivariable analysis, female age (HR 0.97/yr, 95% CI 0.95–0.99), cycle length (HR 0.96/d, 95% CI 0.93–1.0), and FSH levels 8 IU/liter or greater (HR 0.93/IU·liter, 95% CI 0.87–0.99) were strong negative predictors for spontaneous ongoing pregnancy. Addition of FSH to a prediction model based on female age, duration of subfertility, previous pregnancy, referral status, and semen analysis changed the probability to conceive spontaneously from 30% or greater to less than 30% in 97 of 3219 couples (3.0%).

Conclusions: In ovulatory women, a basal FSH level of 8 IU/liter or higher is associated with decreasing fecundity, independent of female age and cycle length. Because the number of couples in whom the FSH level alters management decisions is low, we do not recommend routine testing of basal FSH in subfertile couples.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society